Literature DB >> 16276455

Demographics of hemophilia in developing countries.

Bruce L Evatt1.   

Abstract

Demographic datasets pertaining to populations are extremely valuable tools in healthcare planning. They are vital in setting priorities, allocation of resources, measurement of outcomes, and comparison of alternate approaches. Countries with emerging economies especially need information regarding targeted populations when initiating programs designed to deliver care to persons with chronic conditions such as hemophilia. The problems associated with data collection in these countries are huge but surmountable. The World Federation of Haemophilia (WFH) Global Survey provides a valuable synopsis of current global data on hemophilia patients and has provided insight into the extent of the problem with hemophilia worldwide. More and more countries recognize the uses of these data and have established or are in the process of establishing registries for persons with hemophilia to try and improve the quality of the information provided to the WFH. This information will most certainly assist in guiding the future of hemophilia care in these countries with emerging economies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16276455     DOI: 10.1055/s-2005-922218

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  7 in total

1.  Measuring the quality of haemophilia care across different settings: a set of performance indicators derived from demographics data.

Authors:  A Iorio; J S Stonebraker; M Brooker; J M Soucie
Journal:  Haemophilia       Date:  2016-12-08       Impact factor: 4.287

2.  Social/economic costs and health-related quality of life in patients with rare diseases in Europe.

Authors:  Julio López-Bastida; Juan Oliva-Moreno; Renata Linertová; Pedro Serrano-Aguilar
Journal:  Eur J Health Econ       Date:  2016-03-29

3.  Securing reimbursement for patient centered haemophilia care: major collaborative efforts are needed.

Authors:  Karin C Berger; Brian M Feldman; Joan Wasserman; Wolfgang Schramm; Victor Blanchette; Kathelijn Fischer
Journal:  Haematologica       Date:  2016-03       Impact factor: 9.941

4.  Prominent Mutation of Intron 22 Inversion in Sporadic Hemophilia: Is It Worth the Antenatal Screening?

Authors:  Werasak Sasanakul; Ampaiwan Chuansumrit; Nongnuch Sirachainan; Praguywan Kadegasem
Journal:  Appl Clin Genet       Date:  2022-05-19

5.  Social/economic costs and quality of life in patients with haemophilia in Europe.

Authors:  Marianna Cavazza; Yllka Kodra; Patrizio Armeni; Marta De Santis; Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; László Gulácsi; Johann Matthias Graf von der Schulenburg; Panos Kanavos; Karine Chevreul; Ulf Persson; Giovanni Fattore
Journal:  Eur J Health Econ       Date:  2016-04-05

6.  Direct-to-consumer Marketing to People with Hemophilia.

Authors:  Philip Kucab; Katelyn Dow Stepanyan; Adriane Fugh-Berman
Journal:  PLoS Med       Date:  2016-06-14       Impact factor: 11.069

7.  A survey of characteristics and current educational needs of hemophilia treatment centers within Asia Pacific.

Authors:  Joyce C M Lam; M Joseph John; Alison Street
Journal:  Res Pract Thromb Haemost       Date:  2018-05-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.